These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2046028)

  • 1. In vivo labeling of cocaine binding sites on dopamine transporters with [3H]WIN 35,428.
    Scheffel U; Pögün S; Stathis M; Boja JW; Kuhar MJ
    J Pharmacol Exp Ther; 1991 Jun; 257(3):954-8. PubMed ID: 2046028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter.
    Boja JW; Rahman MA; Philip A; Lewin AH; Carroll FI; Kuhar MJ
    Mol Pharmacol; 1991 Mar; 39(3):339-45. PubMed ID: 1826041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of novel cocaine analogs: a comparison with in vivo receptor binding potency.
    Cline EJ; Scheffel U; Boja JW; Carroll FI; Katz JL; Kuhar MJ
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1174-9. PubMed ID: 1545384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]WIN 35,428 ([3H]CFT) binds to multiple charge-states of the solubilized dopamine transporter in primate striatum.
    Gracz LM; Madras BK
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1224-34. PubMed ID: 7791095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile.
    Kline RH; Izenwasser S; Katz JL; Joseph DB; Bowen WD; Newman AH
    J Med Chem; 1997 Mar; 40(6):851-7. PubMed ID: 9083473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple binding sites for [125I]RTI-121 and other cocaine analogs in rat frontal cerebral cortex.
    Boja JW; Carroll FI; Vaughan RA; Kopajtic T; Kuhar MJ
    Synapse; 1998 Sep; 30(1):9-17. PubMed ID: 9704876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocaine-induced seizures and lethality appear to be associated with distinct central nervous system binding sites.
    Ritz MC; George FR
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1333-43. PubMed ID: 8450469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims.
    Staley JK; Hearn WL; Ruttenber AJ; Wetli CV; Mash DC
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1678-85. PubMed ID: 7996484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halogenated mazindol analogs as potential inhibitors of the cocaine binding site at the dopamine transporter.
    Houlihan WJ; Boja JW; Parrino VA; Kopajtic TA; Kuhar MJ
    J Med Chem; 1996 Dec; 39(25):4935-41. PubMed ID: 8960553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]WIN 35,428 binding in the caudate nucleus of the rabbit: evidence for a single site on the dopamine transporter.
    Aloyo VJ; Ruffin JS; Pazdalski PS; Kirifides AL; Harvey JA
    J Pharmacol Exp Ther; 1995 Apr; 273(1):435-44. PubMed ID: 7714799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related reductions in [3H]WIN 35,428 binding to the dopamine transporter in nigrostriatal and mesolimbic brain regions of the fischer 344 rat.
    Hebert MA; Larson GA; Zahniser NR; Gerhardt GA
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1334-9. PubMed ID: 10027875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
    Kilbourn MR; Kuszpit K; Sherman P
    Synapse; 2000 Mar; 35(4):250-5. PubMed ID: 10657034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between subjective effects of cocaine and dopamine transporter occupancy.
    Volkow ND; Wang GJ; Fischman MW; Foltin RW; Fowler JS; Abumrad NN; Vitkun S; Logan J; Gatley SJ; Pappas N; Hitzemann R; Shea CE
    Nature; 1997 Apr; 386(6627):827-30. PubMed ID: 9126740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dopaminergic drugs on the in vivo binding of [3H]WIN 35,428 to central dopamine transporters.
    Scheffel U; Steinert C; Kim SE; Ehlers MD; Boja JW; Kuhar MJ
    Synapse; 1996 Jun; 23(2):61-9. PubMed ID: 8723710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IPT: a novel iodinated ligand for the CNS dopamine transporter.
    Kung MP; Essman WD; Frederick D; Meegalla S; Goodman M; Mu M; Lucki I; Kung HF
    Synapse; 1995 Aug; 20(4):316-24. PubMed ID: 7482291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, dopamine transporter affinity, dopamine uptake inhibition, and locomotor stimulant activity of 2-substituted 3 beta-phenyltropane derivatives.
    Xu L; Kelkar SV; Lomenzo SA; Izenwasser S; Katz JL; Kline RH; Trudell ML
    J Med Chem; 1997 Mar; 40(6):858-63. PubMed ID: 9083474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WIN 35,428 and mazindol are mutually exclusive in binding to the cloned human dopamine transporter.
    Xu C; Reith ME
    J Pharmacol Exp Ther; 1997 Aug; 282(2):920-7. PubMed ID: 9262359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-amine dopamine transporter probe [(3)H]tropoxene distributes to dopamine-rich regions of monkey brain.
    De La Garza R; Meltzer PC; Madras BK
    Synapse; 1999 Oct; 34(1):20-7. PubMed ID: 10459168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.
    Agoston GE; Wu JH; Izenwasser S; George C; Katz J; Kline RH; Newman AH
    J Med Chem; 1997 Dec; 40(26):4329-39. PubMed ID: 9435902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum.
    Kaufman MJ; Madras BK
    Synapse; 1991 Sep; 9(1):43-9. PubMed ID: 1796351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.